These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1109 related articles for article (PubMed ID: 34932870)

  • 1. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
    Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
    Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations.
    Bayram N; Ozsaygılı C; Sav H; Tekin Y; Gundogan M; Pangal E; Cicek A; Özcan İ
    Jpn J Ophthalmol; 2021 Jul; 65(4):515-525. PubMed ID: 34057620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
    Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
    Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
    Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y;
    Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
    Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
    Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucormycosis as SARS-CoV2 sequelae in kidney transplant recipients: a single-center experience from India.
    Meshram HS; Kute VB; Chauhan S; Dave R; Patel H; Banerjee S; Desai S; Kumar D; Navadiya V; Mishra V
    Int Urol Nephrol; 2022 Jul; 54(7):1693-1703. PubMed ID: 34792722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
    Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
    Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
    [No Abstract]   [Full Text] [Related]  

  • 8. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
    Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
    J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study.
    Dave TV; Gopinathan Nair A; Hegde R; Vithalani N; Desai S; Adulkar N; Kamal S; Mittal R; Bradoo RA
    Ophthalmic Plast Reconstr Surg; 2021 Sep-Oct 01; 37(5):488-495. PubMed ID: 34314399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive use of saturated solution of potassium iodide (SSKI) with liposomal amphotericin B (L-AMB) in mucormycosis achieves favorable response, shortened dose and duration of amphotericin: A retrospective study from a COVID-19 tertiary care center.
    Mrig S; Sardana K; Arora P; Narula V; Arora S; Kapoor A; Baruah RR; Sen P; Agarwal S; Sachdeva S; Dewan A; Panesar S
    Am J Otolaryngol; 2022; 43(3):103465. PubMed ID: 35429848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
    Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rise of the phoenix: Mucormycosis in COVID-19 times.
    Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD
    Indian J Ophthalmol; 2021 Jun; 69(6):1563-1568. PubMed ID: 34011742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience.
    Ramamurthy LB; Bhandari R; Kanakpur S; Thejaswini P
    Indian J Ophthalmol; 2022 Mar; 70(3):1019-1024. PubMed ID: 35225564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.
    Soni K; Das A; Sharma V; Goyal A; Choudhury B; Chugh A; Kumar D; Yadav T; Jain V; Agarwal A; Garg M; Bhatnagar K; Elhence P; Bhatia PK; Garg MK; Misra S
    J Mycol Med; 2022 May; 32(2):101238. PubMed ID: 34979299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis.
    Murthy R; Bagchi A; Gote Y; Desai S
    Indian J Ophthalmol; 2022 Jan; 70(1):302-305. PubMed ID: 34937263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
    Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report.
    Veisi A; Bagheri A; Eshaghi M; Rikhtehgar MH; Rezaei Kanavi M; Farjad R
    Eur J Ophthalmol; 2022 Jul; 32(4):NP11-NP16. PubMed ID: 33843287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of COVID-19-Associated Rhino-Orbital Mucormycosis.
    Arora R; Goel R; Meher R
    JAMA Ophthalmol; 2022 May; 140(5):548. PubMed ID: 35389467
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID Associated Mucormycosis: A Study on the Spectrum of Clinical, Biochemical and Radiological Findings in A Series of Ten Patients.
    Pal P; Chatterjee N; Ghosh S; Ray BK; Mukhopadhyay P; Bhunia K; Srivastava SR; Adhikari S; Barman D; Banerjee B; Mukhopadhyay M; Pal J
    J Assoc Physicians India; 2021 Oct; 69(10):11-12. PubMed ID: 34781648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of COVID-19-Associated Rhino-Orbital Mucormycosis-Reply.
    Date PS; Choksi T; Ingole AB
    JAMA Ophthalmol; 2022 May; 140(5):548-549. PubMed ID: 35389457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 56.